Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships

Université de Montréal

$105,000.00

Implication of CNK in the regulation of RAS/MAPK pathway

FY 2012-13

Summary
Cancer is currently the main cause of mortality in Canada and around 500 people die of it every day. Even with prevention and scientific progress, there is still a severe lack of effective therapeutics to cure cancer. Relapse occurs well too often with more aggressive and frequently metastasized tumours that become resistant to initial treatments. Our laboratory focuses mainly on the RAS/MAPK pathway, whose dysregulation is observed in a third of all human cancers. This pathway comprises enzymes that interact with each other to transmit proliferation signals within the cells. Activating mutations in the small GTPase RAS and the kinase RAF are the most prevalent mutations that cause overactivation of the RAS/MAPK pathway in cancer cells. Components of the RAS/MAPK pathway are highly conserved through evolution, from simple organisms such worms and flies to mammals. Our laboratory takes advantage of the fruit fly Drosophila melanogaster to study this pathway because of the availability of powerful biological tools and the greater simplicity of its genome compared to mammals. Two key proteins required for the RAS/MAPK pathway have been discovered in Drosophila, namely, KSR (Kinase suppressor of RAS) and CNK (Connector eNhancer of KSR). These proteins have the ability to bridge together the central components of the RAS/MAPK pathway, which are known as RAS, RAF, MEK and MAPK. The goal of my project is to delineate at a molecular level the specific impact that CNK impinges on the RAS/MAPK pathway. Given that these proteins are also fund in mammalian cells, this work will contribute to our understanding of the RAS/MAPK pathway and thereby should lead to the development of better anticancer therapeutic agents
Program
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
283906
Name
Bergeron-Labrecque Fanny
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Implication of CNK in the regulation of RAS/MAPK pathway
Programtype2
Studentship Programs
Orgnameinp2
Université de Montréal
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Cancer; Ksr; Protein Interaction; Raf; Ras/Mapk; Signalisation
Abstract
Cancer is currently the main cause of mortality in Canada and around 500 people die of it every day. Even with prevention and scientific progress, there is still a severe lack of effective therapeutics to cure cancer. Relapse occurs well too often with more aggressive and frequently metastasized tumours that become resistant to initial treatments. Our laboratory focuses mainly on the RAS/MAPK pathway, whose dysregulation is observed in a third of all human cancers. This pathway comprises enzymes that interact with each other to transmit proliferation signals within the cells. Activating mutations in the small GTPase RAS and the kinase RAF are the most prevalent mutations that cause overactivation of the RAS/MAPK pathway in cancer cells. Components of the RAS/MAPK pathway are highly conserved through evolution, from simple organisms such worms and flies to mammals. Our laboratory takes advantage of the fruit fly Drosophila melanogaster to study this pathway because of the availability of powerful biological tools and the greater simplicity of its genome compared to mammals. Two key proteins required for the RAS/MAPK pathway have been discovered in Drosophila, namely, KSR (Kinase suppressor of RAS) and CNK (Connector eNhancer of KSR). These proteins have the ability to bridge together the central components of the RAS/MAPK pathway, which are known as RAS, RAF, MEK and MAPK. The goal of my project is to delineate at a molecular level the specific impact that CNK impinges on the RAS/MAPK pathway. Given that these proteins are also fund in mammalian cells, this work will contribute to our understanding of the RAS/MAPK pathway and thereby should lead to the development of better anticancer therapeutic agents
Competitiondate
201210
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Bergeron-Labrecque, Fanny
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~
Université de Montréal - $105,000 Grant (2012-13) | Canada Spends